Barclays’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$932K Sell
30,909
-72,344
-70% -$2.34M ﹤0.01% 2802
2025
Q4
$3.58M Sell
103,253
-3,790
-4% -$134K ﹤0.01% 2479
2025
Q3
$3.89M Buy
107,043
+181
+0.2% +$6.15K ﹤0.01% 2388
2025
Q2
$3.35M Sell
106,862
-228
-0.2% -$7.08K ﹤0.01% 2440
2025
Q1
$3.18M Buy
107,090
+86,465
+419% +$2.59M ﹤0.01% 2278
2024
Q4
$608K Buy
20,625
+19,663
+2,044% +$622K ﹤0.01% 3700
2024
Q3
$29.9K Buy
962
+27
+3% +$982 ﹤0.01% 4842
2024
Q2
$31.7K Sell
935
-6,813
-88% -$347K ﹤0.01% 4352
2024
Q1
$504K Buy
7,748
+167
+2% +$11.5K ﹤0.01% 3588
2023
Q4
$518K Sell
7,581
-57,474
-88% -$2.99M ﹤0.01% 3850
2023
Q3
$3.38M Sell
65,055
-132,086
-67% -$7.82M ﹤0.01% 1570
2023
Q2
$11.8M Sell
197,141
-5,843
-3% -$334K 0.01% 919
2023
Q1
$10M Buy
202,984
+5,856
+3% +$329K 0.01% 1158
2022
Q4
$11.3M Buy
197,128
+196,456
+29,235% +$11.1M 0.01% 1147
2022
Q3
$32K Sell
672
-104
-13% -$4.96K ﹤0.01% 3913
2022
Q2
$29K Sell
776
-332
-30% -$10.8K ﹤0.01% 4258
2022
Q1
$33K Buy
+1,108
New +$28K ﹤0.01% 4273

Other funds holding IMCR